tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Income Statement

Compare
574 Followers

Immuneering Income Statement

Last quarter (Q3 2025), Immuneering's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Immuneering's net income was $-14.96M. See Immuneering’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 316.95K$ 2.08M$ 2.31M
Gross Profit
$ 0.00$ 0.00$ 158.83K$ 926.89K$ 1.03M
Operating Expenses
$ 64.07M$ 58.41M$ 51.90M$ 34.81M$ 18.11M
Depreciation and Amortization
$ 385.07K$ 352.08K$ 277.25K$ 159.07K$ 79.31K
EBITDA
$ -63.69M$ -58.06M$ -51.47M$ -33.73M$ -17.00M
Operating Income
$ -64.07M$ -58.41M$ -51.74M$ -33.89M$ -17.08M
Other Income/Expenses
$ 3.03M$ 4.94M$ 1.23M$ 42.83K$ -41.70K
Pretax Income
$ -61.04M$ -53.47M$ -50.51M$ -33.84M$ -17.12M
Net Income
$ -61.04M$ -53.47M$ -50.51M$ -33.54M$ -17.04M
Per Share Metrics
Basic EPS
$ -2.04$ -1.88$ -1.87$ -1.27$ -1.26
Diluted EPS
$ -2.04$ -1.88$ -1.87$ -1.27$ -1.26
Weighted Average Shares Outstanding
29.98M 28.42M 26.39M 26.32M 13.51M
Weighted Average Shares Outstanding (Diluted)
29.98M 28.42M 26.39M 26.32M 13.51M
Currency in USD

Immuneering Earnings and Revenue History